Skip to content
← Back to this collection

PUBLICATIONS · 22498739

Effects of induction and maintenance plus long-term bisphosphonates on bone disease in patients with multiple myeloma: the Medical Research Council Myeloma IX Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2012 Jun 7
First author
Morgan GJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Morgan GJ
      type
      Author
    2. name
      Davies FE
      type
      Author
    3. name
      Gregory WM
      type
      Author
    4. name
      Szubert AJ
      type
      Author
    5. name
      Bell SE
      type
      Author
    6. name
      Drayson MT
      type
      Author
    7. name
      Owen RG
      type
      Author
    8. name
      Ashcroft AJ
      type
      Author
    9. name
      Jackson GH
      type
      Author
    10. name
      Child JA
      type
      Author
    11. name
      National Cancer Research Institute Haematological Oncology Clinical Studies Group
      type
      CollectiveName
    Complete bibliographic record and source provenance
    authors
    1. name
      Morgan GJ
      type
      Author
    2. name
      Davies FE
      type
      Author
    3. name
      Gregory WM
      type
      Author
    4. name
      Szubert AJ
      type
      Author
    5. name
      Bell SE
      type
      Author
    6. name
      Drayson MT
      type
      Author
    7. name
      Owen RG
      type
      Author
    8. name
      Ashcroft AJ
      type
      Author
    9. name
      Jackson GH
      type
      Author
    10. name
      Child JA
      type
      Author
    11. name
      National Cancer Research Institute Haematological Oncology Clinical Studies Group
      type
      CollectiveName
    bibliography ids
    1. nci-bib-d642322203b7e3ea44030ba1
    book metadata
    content sha256
    efd92221de706e24a18993d015794022ba436bbc8ea4dde122ba14869c04daed
    document type
    citation
    dois
    1. 10.1182/blood-2011-11-392522
    electronic publication date
    display
    2012 Apr 12
    precision
    day
    year
    2012
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:22498739
    immutable id
    pubmed:22498739@efd92221de706e24a18993d015794022ba436bbc8ea4dde122ba14869c04daed
    journal
    abbreviation
    Blood
    issn electronic
    1528-0020
    issn print
    0006-4971
    issue
    23
    name
    Blood
    nlm unique id
    7603509
    pages
    5374-83
    volume
    119
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      22498739
      provenance
      batch id
      c95be1d0b8cf19942816
      provider
      NCBI PubMed ESummary
      record sha256
      d9283d573cf5127caa6ae0fa59d85ee15924de3d7c0ec2184a21679042ab9d58
      response sha256
      a96bb680a8f3690267e009557d1b07aab71455ba44aeba18695d98a3eeb5fcf2
      retrieved at
      2026-09-09T23:46:47.691937+00:00
      publication date
      display
      2012 Jun 7
      precision
      day
      year
      2012
      publication types
      1. Journal Article
      2. Randomized Controlled Trial
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/22498739/
      title
      Effects of induction and maintenance plus long-term bisphosphonates on bone disease in patients with multiple myeloma: the Medical Research Council Myeloma IX Trial.

      Preserved source evidence · Not medical advice